AXQ Capital’s Terns Pharmaceuticals TERN Stock Holding History

AXQ Capital’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,410	Closed	-$496K	–	1346
2026 Q1	$496K	Buy	9,410 +2,342	+33%	+$96.2K	0.06%	420
2025 Q4	$286K	Buy	+7,068	New	+$163K	0.06%	453
2025 Q2	–	Sell	-21,460	Closed	-$59.2K	–	774
2025 Q1	$59.2K	Buy	+21,460	New	+$87.6K	0.02%	464
2024 Q4	–	Sell	-11,172	Closed	-$93.2K	–	619
2024 Q3	$93.2K	Buy	+11,172	New	+$91.9K	0.03%	406

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AXQ Capital's TERN Position: Q2 2026 in Review

AXQ Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 9,410 shares — an estimated $496K sold.

AXQ Capital first reported a position in TERN in Q3 2024 and held it in 4 quarters. The position peaked at $496K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

AXQ Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 9,410 Terns Pharmaceuticals shares in Q2 2026, an estimated $496K.
AXQ Capital first reported a position in Terns Pharmaceuticals in Q3 2024 and held it in 4 quarters.
AXQ Capital's Terns Pharmaceuticals position peaked at $496K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.